FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318916999> ?p ?o ?g. }

• W4318916999 abstract "Abstract Context Iron deficiency and anemia have serious consequences, especially for children and pregnant women. Iron salts are commonly provided as oral supplements to prevent and treat iron deficiency, despite poor bioavailability and frequently reported adverse side effects. Ferrous bisglycinate is a novel amino acid iron chelate that is thought to be more bioavailable and associated with fewer gastrointestinal (GI) adverse events as compared with iron salts. Objective A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to evaluate the effects of ferrous bisglycinate supplementation compared with other iron supplements on hemoglobin and ferritin concentrations and GI adverse events. Data sources A systematic search of electronic databases and grey literature was performed up to July 17, 2020, yielding 17 RCTs that reported hemoglobin or ferritin concentrations following at least 4 weeks’ supplementation of ferrous bisglycinate compared with other iron supplements in any dose or frequency. Data extraction Random-effects meta-analyses were conducted among trials of pregnant women (n = 9) and children (n = 4); pooled estimates were expressed as standardized mean differences (SMDs). Incidence rate ratios (IRRs) were estimated for GI adverse events, using Poisson generalized linear mixed-effects models. The remaining trials in other populations (n = 4; men and nonpregnant women) were qualitatively evaluated. Data analysis Compared with other iron supplements, supplementation with ferrous bisglycinate for 4–20 weeks resulted in higher hemoglobin concentrations in pregnant women (SMD, 0.54 g/dL; 95% confidence interval [CI], 0.15–0.94; P &lt; 0.01) and fewer reported GI adverse events (IRR, 0.36; 95%CI, 0.17–0.76; P &lt; 0.01). We observed a non-significant trend for higher ferritin concentrations in pregnant women supplemented with ferrous bisglycinate. No significant differences in hemoglobin or ferritin concentrations were detected among children. Conclusion Ferrous bisglycinate shows some benefit over other iron supplements in increasing hemoglobin concentration and reducing GI adverse events among pregnant women. More trials are needed to assess the efficacy of ferrous bisglycinate against other iron supplements in other populations. PROSPERO registration no CRD42020196984." @default.
• W4318916999 created "2023-02-03" @default.
• W4318916999 creator A5034285385 @default.
• W4318916999 creator A5044621598 @default.
• W4318916999 creator A5044838244 @default.
• W4318916999 creator A5082112381 @default.
• W4318916999 date "2023-02-02" @default.
• W4318916999 modified "2023-10-01" @default.
• W4318916999 title "The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials" @default.
• W4318916999 cites W1654771448 @default.
• W4318916999 cites W172974521 @default.
• W4318916999 cites W1870257566 @default.
• W4318916999 cites W1963301324 @default.
• W4318916999 cites W1993258922 @default.
• W4318916999 cites W2003707184 @default.
• W4318916999 cites W2009878128 @default.
• W4318916999 cites W2011497294 @default.
• W4318916999 cites W2021593215 @default.
• W4318916999 cites W2049123117 @default.
• W4318916999 cites W2053812230 @default.
• W4318916999 cites W2081449431 @default.
• W4318916999 cites W2088097018 @default.
• W4318916999 cites W2097209998 @default.
• W4318916999 cites W2099880429 @default.
• W4318916999 cites W2102763290 @default.
• W4318916999 cites W2126439962 @default.
• W4318916999 cites W2130601361 @default.
• W4318916999 cites W2138003397 @default.
• W4318916999 cites W2142399448 @default.
• W4318916999 cites W2144955797 @default.
• W4318916999 cites W2145894801 @default.
• W4318916999 cites W2152312849 @default.
• W4318916999 cites W2156098321 @default.
• W4318916999 cites W2158305865 @default.
• W4318916999 cites W2160894879 @default.
• W4318916999 cites W2167985922 @default.
• W4318916999 cites W2168095126 @default.
• W4318916999 cites W2284899967 @default.
• W4318916999 cites W2568910824 @default.
• W4318916999 cites W2626874314 @default.
• W4318916999 cites W2739145801 @default.
• W4318916999 cites W2748830120 @default.
• W4318916999 cites W2749069611 @default.
• W4318916999 cites W2767155035 @default.
• W4318916999 cites W2784404864 @default.
• W4318916999 cites W2805207619 @default.
• W4318916999 cites W2895372131 @default.
• W4318916999 cites W2970684805 @default.
• W4318916999 cites W2972358277 @default.
• W4318916999 cites W2991792334 @default.
• W4318916999 cites W3040165917 @default.
• W4318916999 cites W3042134445 @default.
• W4318916999 cites W4211085194 @default.
• W4318916999 doi "https://doi.org/10.1093/nutrit/nuac106" @default.
• W4318916999 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36728680" @default.
• W4318916999 hasPublicationYear "2023" @default.
• W4318916999 type Work @default.
• W4318916999 citedByCount "2" @default.
• W4318916999 countsByYear W43189169992023 @default.
• W4318916999 crossrefType "journal-article" @default.
• W4318916999 hasAuthorship W4318916999A5034285385 @default.
• W4318916999 hasAuthorship W4318916999A5044621598 @default.
• W4318916999 hasAuthorship W4318916999A5044838244 @default.
• W4318916999 hasAuthorship W4318916999A5082112381 @default.
• W4318916999 hasConcept C126322002 @default.
• W4318916999 hasConcept C151730666 @default.
• W4318916999 hasConcept C168563851 @default.
• W4318916999 hasConcept C178790620 @default.
• W4318916999 hasConcept C181389837 @default.
• W4318916999 hasConcept C185592680 @default.
• W4318916999 hasConcept C197934379 @default.
• W4318916999 hasConcept C2775832776 @default.
• W4318916999 hasConcept C2776732101 @default.
• W4318916999 hasConcept C2777417653 @default.
• W4318916999 hasConcept C2778248108 @default.
• W4318916999 hasConcept C2778319317 @default.
• W4318916999 hasConcept C2778917026 @default.
• W4318916999 hasConcept C2779343474 @default.
• W4318916999 hasConcept C44249647 @default.
• W4318916999 hasConcept C71924100 @default.
• W4318916999 hasConcept C86803240 @default.
• W4318916999 hasConcept C90924648 @default.
• W4318916999 hasConcept C95190672 @default.
• W4318916999 hasConcept C98274493 @default.
• W4318916999 hasConceptScore W4318916999C126322002 @default.
• W4318916999 hasConceptScore W4318916999C151730666 @default.
• W4318916999 hasConceptScore W4318916999C168563851 @default.
• W4318916999 hasConceptScore W4318916999C178790620 @default.
• W4318916999 hasConceptScore W4318916999C181389837 @default.
• W4318916999 hasConceptScore W4318916999C185592680 @default.
• W4318916999 hasConceptScore W4318916999C197934379 @default.
• W4318916999 hasConceptScore W4318916999C2775832776 @default.
• W4318916999 hasConceptScore W4318916999C2776732101 @default.
• W4318916999 hasConceptScore W4318916999C2777417653 @default.
• W4318916999 hasConceptScore W4318916999C2778248108 @default.
• W4318916999 hasConceptScore W4318916999C2778319317 @default.
• W4318916999 hasConceptScore W4318916999C2778917026 @default.
• W4318916999 hasConceptScore W4318916999C2779343474 @default.
• W4318916999 hasConceptScore W4318916999C44249647 @default.
• W4318916999 hasConceptScore W4318916999C71924100 @default.

• next